Delivery Order SPE2DB20D7066-SPE2DB25FC2KG

Award Date 2/24/25
Potential Completion Date 2/25/25
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, with a ceiling value of $1,638.80 and a period of performance through February 5, 2025. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,695.26, is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product. The contract is a firm fixed-price delivery order with an ultimate completion date of July 26, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, with a ceiling value of $1,856.46 and a period of performance through January 25, 2024. The contract was awarded on a firm fixed-price basis without any set-aside requirements, indicating open competition. AmerisourceBergen holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,459.76, is for the supply of SYNVISC-ONE SYRINGE 6ML, a specialty medical product, with a period of performance through August 7, 2024. The contract is not designated as a set-aside. In addition to this specific delivery order, AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SYNVISC-ONE SYRINGE 6ML, a specialty medical product. The firm-fixed-price contract, valued at $3,503.46, has a period of performance through November 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of SYNVISC-ONE SYRINGE 6ML. The contract has a ceiling value of $7,319.96 and is a firm-fixed price arrangement with an ultimate completion date of September 23, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,276.31, is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product. This contract does not have a set-aside designation, indicating it was competitively awarded. The contract is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,562.24 firm-fixed-price delivery order is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, with a period of performance through March 17, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, with a ceiling value of $2,748.45 and a period of performance through January 8, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical device used for the treatment of osteoarthritis. The contract has a ceiling value of $7,867.67 and an ultimate completion date of May 5, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open...
  • SPE2DB20D7066
    Indefinite Delivery Contract
  • SPE2DB20D7066-SPE2DB25FC2KG
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,540.64, is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product. The contract has a firm fixed price and runs until February 25, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/1/25, 3:36 AM